Top compounds associated with response to LCE1B


Feature Type Standardized
Nominal ANOVA
mRNA tanespimycin:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.057 0.1
mRNA BRD-A05715709 CTRPv2 pan-cancer AAC -0.085 0.1
mRNA JW-7-24-1 GDSC1000 pan-cancer AAC 0.046 0.1
mRNA BEC CTRPv2 pan-cancer AAC 0.11 0.1
mRNA AZ628 GDSC1000 pan-cancer AAC 0.075 0.1
mRNA JQ12 GDSC1000 pan-cancer AAC -0.054 0.1
mRNA Parthenolide GDSC1000 pan-cancer AAC -0.08 0.1
mRNA Vinorelbine GDSC1000 pan-cancer AAC -0.053 0.1
mRNA RDEA119 GDSC1000 pan-cancer AAC 0.046 0.1
mRNA selumetinib:PLX-4032 (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.053 0.1
Download CSV